These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38326487)

  • 1. Effectiveness of antipsychotics for managing agitated delirium in patients with advanced cancer: a secondary analysis of a multicenter prospective observational study in Japan (Phase-R).
    Kurisu K; Inada S; Maeda I; Nobata H; Ogawa A; Iwase S; Uchida M; Akechi T; Amano K; Nakajima N; Morita T; Sumitani M; Yoshiuchi K
    Support Care Cancer; 2024 Feb; 32(3):147. PubMed ID: 38326487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Pharmacological Treatments for Agitated Delirium in the Last Days of Life.
    Kawashima N; Yokomichi N; Morita T; Yabuki R; Hisanaga T; Imai K; Hirose Y; Shimokawa M; Miwa S; Yamauchi T; Okamoto S; Satomi E
    J Pain Symptom Manage; 2024 May; 67(5):441-452.e3. PubMed ID: 38355071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous olanzapine for hyperactive or mixed delirium in patients with advanced cancer: a preliminary study.
    Elsayem A; Bush SH; Munsell MF; Curry E; Calderon BB; Paraskevopoulos T; Fadul N; Bruera E
    J Pain Symptom Manage; 2010 Nov; 40(5):774-82. PubMed ID: 20728301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visualizing How to Use Antipsychotics for Agitated Delirium in the Last Days of Life.
    Imai K; Morita T; Mori M; Kiuchi D; Yokomichi N; Miwa S; Okamoto S; Yamauchi T; Naito AS; Matsuda Y; Maeda I; Sugano K; Ikenaga M; Inoue S; Satomi E
    J Pain Symptom Manage; 2023 Jun; 65(6):479-489. PubMed ID: 36682673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial.
    Hui D; De La Rosa A; Wilson A; Nguyen T; Wu J; Delgado-Guay M; Azhar A; Arthur J; Epner D; Haider A; De La Cruz M; Heung Y; Tanco K; Dalal S; Reddy A; Williams J; Amin S; Armstrong TS; Breitbart W; Bruera E
    Lancet Oncol; 2020 Jul; 21(7):989-998. PubMed ID: 32479786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial.
    Hui D; Frisbee-Hume S; Wilson A; Dibaj SS; Nguyen T; De La Cruz M; Walker P; Zhukovsky DS; Delgado-Guay M; Vidal M; Epner D; Reddy A; Tanco K; Williams J; Hall S; Liu D; Hess K; Amin S; Breitbart W; Bruera E
    JAMA; 2017 Sep; 318(11):1047-1056. PubMed ID: 28975307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-Generation Parenteral Antipsychotic (Olanzapine) as a First-Line Treatment for Acute Undifferentiated Agitation in the Emergency Department in Comparison With Haloperidol.
    Singh AP; Murali Mohan NT
    Cureus; 2023 Jun; 15(6):e40226. PubMed ID: 37435257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine Versus Haloperidol for Treatment of Delirium in Patients with Advanced Cancer: A Phase III Randomized Clinical Trial.
    van der Vorst MJDL; Neefjes ECW; Boddaert MSA; Verdegaal BATT; Beeker A; Teunissen SCC; Beekman ATF; Wilschut JA; Berkhof J; Zuurmond WWA; Verheul HMW
    Oncologist; 2020 Mar; 25(3):e570-e577. PubMed ID: 32162816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug therapy for delirium in terminally ill adults.
    Finucane AM; Jones L; Leurent B; Sampson EL; Stone P; Tookman A; Candy B
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004770. PubMed ID: 31960954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prehospital Agitation and Sedation Trial (PhAST): A Randomized Control Trial of Intramuscular Haloperidol versus Intramuscular Midazolam for the Sedation of the Agitated or Violent Patient in the Prehospital Environment.
    Isenberg DL; Jacobs D
    Prehosp Disaster Med; 2015 Oct; 30(5):491-5. PubMed ID: 26323511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized sedation goal for agitated delirium in patients with cancer: Balancing comfort and communication.
    Hui D; De La Rosa A; Urbauer DL; Nguyen T; Bruera E
    Cancer; 2021 Dec; 127(24):4694-4701. PubMed ID: 34432293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotics for delirium.
    Lonergan E; Britton AM; Luxenberg J; Wyller T
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005594. PubMed ID: 17443602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The minimal clinically important difference of the Richmond Agitation-Sedation Scale in patients with cancer with agitated delirium.
    Hui D; Hess K; Dibaj SS; Arthur J; Dev R; Dalal S; Reddy S; Bruera E
    Cancer; 2018 May; 124(10):2246-2252. PubMed ID: 29469951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic Management of Intensive Care Unit Delirium: Clinical Prescribing Practices and Outcomes in More Than 8500 Patient Encounters.
    Boncyk CS; Farrin E; Stollings JL; Rumbaugh K; Wilson JE; Marshall M; Feng X; Shotwell MS; Pandharipande PP; Hughes CG
    Anesth Analg; 2021 Sep; 133(3):713-722. PubMed ID: 33433117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Richmond Agitation-Sedation Scale modified for palliative care inpatients (RASS-PAL): a pilot study exploring validity and feasibility in clinical practice.
    Bush SH; Grassau PA; Yarmo MN; Zhang T; Zinkie SJ; Pereira JL
    BMC Palliat Care; 2014 Mar; 13(1):17. PubMed ID: 24684942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium.
    Yoon HJ; Park KM; Choi WJ; Choi SH; Park JY; Kim JJ; Seok JH
    BMC Psychiatry; 2013 Sep; 13():240. PubMed ID: 24074357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Effectiveness of Perospirone in Comparison to Risperidone for Treatment of Delirium in Patients with Advanced Cancer: A Multicenter Prospective Observational Study in Real-World Psycho-Oncology Settings.
    Inoue S; Maeda I; Ogawa A; Yoshiuchi K; Terada S; Yamada N
    Acta Med Okayama; 2022 Apr; 76(2):195-202. PubMed ID: 35503448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association among rescue neuroleptic use, agitation, and perceived comfort: secondary analysis of a randomized clinical trial on agitated delirium.
    Tang M; Chen M; Bruera E; Hui D
    Support Care Cancer; 2021 Dec; 29(12):7887-7894. PubMed ID: 34184130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Pharmacotherapy Does Not Improve Severity of Hypoactive Delirium in Patients with Advanced Cancer: Pharmacological Audit Study of Safety and Efficacy in Real World (Phase-R).
    Okuyama T; Yoshiuchi K; Ogawa A; Iwase S; Yokomichi N; Sakashita A; Tagami K; Uemura K; Nakahara R; Akechi T;
    Oncologist; 2019 Jul; 24(7):e574-e582. PubMed ID: 30610009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Tolerability of Atypical Antipsychotics in the Treatment of Delirium: A Systematic Review of the Literature.
    Rivière J; van der Mast RC; Vandenberghe J; Van Den Eede F
    Psychosomatics; 2019; 60(1):18-26. PubMed ID: 30181002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.